Revvity (LTS:0KHE) Shares Outstanding (EOP): 112 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0KHE Revvity Inc LTS:0KHE
75 GF Score
Price $112.05
GF Value $121.44
Valuation Fairly Valued
! 11 Warning Signs
View Full Analysis

What is Revvity Shares Outstanding (EOP)?

Revvity LTS:0KHE +0.28% 75 Shares Outstanding (EOP) is 112 Mil as of Mar. 2026. GuruFocus rates LTS:0KHE with a GF Score™ of 75/100 and a GF Value™ of $121.44 (Fairly Valued). The stock has 11 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Revvity's shares outstanding for the quarter that ended in Mar. 2026 was 112 Mil.

Revvity's quarterly shares outstanding declined from Dec. 2025 (112 Mil) to Mar. 2026 (112 Mil). It means Revvity bought back shares from Dec. 2025 to Mar. 2026 .

Revvity's annual shares outstanding declined from Dec. 2024 (121 Mil) to Dec. 2025 (112 Mil). It means Revvity bought back shares from Dec. 2024 to Dec. 2025 .


Revvity  (LTS:0KHE) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Revvity Shares Outstanding (EOP) Related Terms


Revvity Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Revvity's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revvity Shares Outstanding (EOP) Chart

Revvity Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 126.24 126.30 123.43 120.65 112.28

Revvity Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 119.41 116.33 114.03 112.28 111.63

LTS:0KHE vs ICLR, CRL, MEDP: Shares Outstanding (EOP) Comparison

For the Diagnostics & Research subindustry, Revvity's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revvity Shares Outstanding (EOP) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Revvity's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Revvity's Shares Outstanding (EOP) falls into.


LTS:0KHE
75GF Score
Revvity Inc LTS:0KHE
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revvity Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 112 Mil mean?
Revvity (LTS:0KHE) has a Shares Outstanding (EOP) of 112 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on Revvity and its competitors.
Is Revvity's Shares Outstanding (EOP) too high?
Revvity's current Shares Outstanding (EOP) is 112 Mil. Overall, Revvity has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Revvity's Shares Outstanding (EOP) compare to ICLR and CRL?
Revvity's Shares Outstanding (EOP) of 112 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Diagnostics & Research company?
A good Shares Outstanding (EOP) depends on the Medical Diagnostics & Research industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Revvity and its competitors. Revvity's current Shares Outstanding (EOP) is 112 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revvity stock overvalued right now?
Based on GuruFocus' analysis, Revvity (LTS:0KHE) is currently considered Fairly Valued. The stock's GF Value™ is $121.44, compared to a current price of $112.05 — trading 7.7% below its estimated fair value. The current Shares Outstanding (EOP) is 112 Mil. Revvity's overall GF Score™ is 75/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Revvity (LTS:0KHE), the current Shares Outstanding (EOP) is 112 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Revvity (LTS:0KHE) Overvalued in 2026?

Based on GuruFocus' analysis, Revvity stock appears to be undervalued. The current stock price of $112.05 is trading 7.7% below its estimated GF Value™ of $121.44. GuruFocus considers Revvity to be Fairly Valued.

Key valuation signals for LTS:0KHE:

  • Shares Outstanding (EOP): 112 Mil
  • GF Value™: $121.44 vs. price of $112.05 (7.7% below fair value)
  • GF Score™: 75/100 with 11 warning signs

No single metric tells the full story. See the LTS:0KHE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Revvity Business Description

Address 77 4th Avenue, Waltham, MA, USA, 02451
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
75GF Score

Get the complete analysis for LTS:0KHE

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$112.05
Price
$121.44
GF Value